Meta-Analysis of New-Onset Atrial Fibrillation Versus No History of Atrial Fibrillation in Patients With Noncardiac Critical Care Illness.

Document Type

Article

Publication Date

2-1-2022

Publication Title

American Journal of Cardiology

Abstract

The incidence of new-onset secondary atrial fibrillation (NOSAF) is as high as 44% in noncardiac critical illness. A systematic review and meta-analysis were performed to evaluate the impact of NOSAF, compared with history of prior atrial fibrillation (AF) and no history of AF in noncardiac critically ill patients. Patients undergoing cardiothoracic surgery were excluded. NOSAF incidence, intensive care unit (ICU)/hospital length of stay (LOS), and mortality outcomes were analyzed. Of 2,360 studies reviewed, 19 studies met inclusion criteria (n = 306,805 patients). NOSAF compared with no history of AF was associated with increased in-hospital mortality (risk ratio [RR] 2.06, 95% confidence interval [CI] 1.76 to 2.41, p1 year) mortality (RR 1.76, 95% CI 1.29 to 2.40, p

Volume

164

First Page

57

Last Page

63

DOI

10.1016/j.amjcard.2021.10.036

ISSN

1879-1913

PubMed ID

34815061

Link to Full Text

Share

COinS